Celldex Therapeutics
The Director, Clinical Science leads the design, execution, and data interpretation of clinical development programs for innovative therapies. This strategic scientific leader collaborates with cross‑functional teams to shape study protocols, drive data‑driven decisions, and support regulatory submissions, while mentoring clinical scientists.
Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering immunology-based therapies to treat severe inflammatory, allergic, and autoimmune diseases. Their lead program, barzolvolimab, is a humanized monoclonal antibody inhibitor of KIT designed to target mast cells as a core driver of disease. The company leverages deep expertise in antibody-based immunotherapies and proprietary technologies to discover and develop innovative treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celldex Therapeutics.
13% below the average for this role
Director, Clinical Scientist
Spyre Therapeutics
Senior Clinical Scientist
Merck & Co., Inc.
Clinical Development Scientist/Senior Clinical Development Scientist
Tenvie Therapeutics
Director, Clinical Science
Pathos
Senior Director, Clinical Science
CytomX Therapeutics
Associate Director, Clinical Science
Transforming Hypertrophic Cardiomyopathy Care